ITeos Therapeutics Funding: $205M Raised, Series B (2020)
ITeos Therapeutics has raised $205M in total funding. Latest round: Series B. Backed by RA Capital Management, Boxer Capital, Janus Henderson Investors.
ITeos Therapeutics funding overview
ITeos Therapeutics has raised $205M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2020. The round record for ITeos Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include RA Capital Management, Boxer Capital, Janus Henderson Investors, RTW Investments, Invus, MPM Capital and 7 others. 13 distinct backers are named across the disclosed rounds.
ITeos Therapeutics at a glance
Total raised
$205M
Latest round
Series B
Latest round date
April 2020
Notable investors
RA Capital Management, Boxer Capital, Janus Henderson Investors, RTW Investments, Invus, MPM Capital, HBM Partners, 6 Dimensions Capital
Frequently asked about ITeos Therapeutics funding
How much has ITeos Therapeutics raised?
ITeos Therapeutics has raised $205M in total disclosed funding across the rounds on record.
Who has invested in ITeos Therapeutics?
RA Capital Management, Boxer Capital, Janus Henderson Investors, RTW Investments, Invus, MPM Capital are named among the investors backing ITeos Therapeutics.
What was the latest ITeos Therapeutics funding round?
The most recent disclosed round is a Series B, announced in April 2020.
Where is ITeos Therapeutics based?
No headquarters location is disclosed for ITeos Therapeutics.
When did ITeos Therapeutics last raise?
The last disclosed ITeos Therapeutics round closed in April 2020 at Series B.
We update the ITeos Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
